Starbucks plans to tap into consumers’ protein obsession by launching protein-packed cold foam and lattes starting Sept. 29. From “gym bros” to users of GLP-1 drugs like Ozempic, many Americans are … [+2104 chars]Read More
Eli Lilly blows past quarterly estimates posts strong outlook as Zepbound and Mounjaro sales soar…
Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.
